 1.  Public disclosure of information submitted to FDA for authorizing emergency use of, or licensing, any COVID–19 vaccine  Not later than 100 days after the date of enactment of this Act, the Commissioner of Food and Drugs shall make available for public inspection all records of information submitted to the Food and Drug Administration in conjunction with authorizing the emergency use of, or licensing, a COVID–19 vaccine. 
